Novavax to Participate in the Citi 12th Annual Biotech Conference

GAITHERSBURG, Md., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced the Company will participate in Citi’s 12th Annual Biotech Conference.

Conference details are as follows:

Date: Thursday, September 7, 2017Location: Mandarin Oriental hotel, Boston, MA

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor Relations
[email protected]
240-268-2000

Westwicke Partners
John Woolford
[email protected]
443-213-0506

Media
Russo Partners, LLC
David Schull
Maggie Beller
[email protected]
[email protected]
212-845-4271

You May Also Be Interested In

• G Mining Ventures Completes Second and Final Draw on $75 Million Term Loan from Franco-Nevada
• JetBlue Announces First Quarter 2024 Results
• Forward Air Announces Leadership Transition